Power Law company profile

Deciphera Pharmaceuticals

Biotech & Life Sciences · Waltham, United States · Founded 2003 · IPO 2017 Unicorn

A clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the effectiveness of many cancer therapies

Valuation

$1.97B

Market cap · 2026

Revenue

$170M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

7 investors on Deciphera Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Sphera Global Healthcare Fund

New Leaf Venture Partners

SV Health Investors

Deciphera Pharmaceuticals

Redmile Group

Sphera Funds Management

Viking Global Investors

Global footprint

Where Deciphera Pharmaceuticals has talent and traffic

AI talent share

0.4% of workforce is AI talent
(2 of 535 staff)

Core AI10.19%

Other AI10.19%

Non-AI workforce53399.63%

Workforce by country

10 countries with
team presence

🇺🇸 United States86.2%

🇨🇭 Switzerland4.5%

🇩🇪 Germany2.9%

🇫🇷 France1.9%

🇳🇱 Netherlands1.2%

Top 5 of 10 shown

Web traffic by country

13K monthly visits
across markets

🇺🇸 United States66.9%

🇬🇧 United Kingdom12.3%

🇯🇵 Japan11.5%

🇨🇦 Canada7.7%

🇮🇹 Italy1.5%

Top 5 markets shown

Patent intelligence

$133M patent portfolio · 112 active families

Estimated portfolio value

$133M

6.8% of market cap · 3.4× the top peer TESARO ($39M)

112 active patent families

Where Deciphera Pharmaceuticals innovates Cancer researchMolecular biologyCarcinosisDiseaseKinase inhibition

Where Deciphera Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Deciphera Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Deciphera Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Deciphera Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Deciphera Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles